BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11502813)

  • 1. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
    Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
    J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas.
    Lania A; Persani L; Ballaré E; Mantovani S; Losa M; Spada A
    J Clin Endocrinol Metab; 1998 May; 83(5):1624-8. PubMed ID: 9589667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
    Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
    Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y; Tang D; Deng J; Su C
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.
    Kim E; Sohn S; Lee M; Park C; Jung J; Park S
    Pituitary; 2005; 8(2):155-62. PubMed ID: 16379030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
    Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic changes in human pituitary adenomas].
    Spada A; Lania A
    Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
    Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
    J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
    Lania A; Mantovani G; Ferrante E; Zavanone LM; Locatelli M; Corbetta S; Beck-Peccoz P; Spada A
    J Endocrinol Invest; 2004 Apr; 27(4):328-33. PubMed ID: 15233551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
    Barlier A; Gunz G; Zamora AJ; Morange-Ramos I; Figarella-Branger D; Dufour H; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas.
    Persani L; Lania A; Alberti L; Romoli R; Mantovani G; Filetti S; Spada A; Conti M
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2872-8. PubMed ID: 10946896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS imprinting and pituitary tumors.
    Mantovani G; Lania AG; Spada A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
    Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein abnormalities in pituitary adenomas.
    Spada A; Lania A; Ballarè E
    Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein.
    Kim K; Sanno N; Arai K; Takano K; Yasufuku-Takano J; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas.
    Bertherat J; Chanson P; Montminy M
    Mol Endocrinol; 1995 Jul; 9(7):777-83. PubMed ID: 7476961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional overexpression of the wild-type Gs alpha as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines.
    Romano D; Magalon K; Pertuit M; Rasolonjanahary R; Barlier A; Enjalbert A; Gerard C
    Endocrinology; 2007 Jun; 148(6):2973-83. PubMed ID: 17363453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.